Revelation Biosciences, Inc.Revelation Biosciences, Inc.Revelation Biosciences, Inc.

Revelation Biosciences, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪3.45 M‬USD
‪−120.25 K‬USD
‪1.63 M‬
Beta (1Y)

About Revelation Biosciences, Inc.

James M. Rolke
San Diego
Employees (FY)
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which focuses on the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. The company was founded on November 20, 2019 and is headquartered in San Diego, CA.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of REVB is 2.40 USD — it has increased by 13.74% in the past 24 hours. Watch Revelation Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Revelation Biosciences, Inc. stocks are traded under the ticker REVB.
REVB stock has risen by 10.60% compared to the previous week, the month change is a 26.31% rise, over the last year Revelation Biosciences, Inc. has showed a 92.23% decrease.
We've gathered analysts' opinions on Revelation Biosciences, Inc. future price: according to them, REVB price has a max estimate of 25.00 USD and a min estimate of 12.40 USD. Watch REVB chart and read a more detailed Revelation Biosciences, Inc. stock forecast: see what analysts think of Revelation Biosciences, Inc. and suggest that you do with its stocks.
REVB reached its all-time high on Jan 5, 2022 with the price of 11854.50 USD, and its all-time low was 1.61 USD and was reached on May 30, 2024. View more price dynamics on REVB chart.
See other stocks reaching their highest and lowest prices.
REVB stock is 71.61% volatile and has beta coefficient of 0.35. Track Revelation Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Revelation Biosciences, Inc. there?
Today Revelation Biosciences, Inc. has the market capitalization of ‪3.92 M‬, it has decreased by 6.28% over the last week.
Yes, you can track Revelation Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Revelation Biosciences, Inc. is going to release the next earnings report on Aug 12, 2024. Keep track of upcoming events with our Earnings Calendar.
REVB earnings for the last quarter are −2.46 USD per share, whereas the estimation was −5.39 USD resulting in a 54.32% surprise. The estimated earnings for the next quarter are −1.81 USD per share. See more details about Revelation Biosciences, Inc. earnings.
Revelation Biosciences, Inc. revenue for the last quarter amounts to 0 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
REVB net income for the last quarter is ‪−2.68 M‬ USD, while the quarter before that showed ‪−2.20 M‬ USD of net income which accounts for −21.72% change. Track more Revelation Biosciences, Inc. financial stats to get the full picture.
No, REVB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 25, 2024, the company has 9.00 employees. See our rating of the largest employees — is Revelation Biosciences, Inc. on this list?
Like other stocks, REVB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Revelation Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Revelation Biosciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Revelation Biosciences, Inc. stock shows the sell signal. See more of Revelation Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.